MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC

  1. Dansin, E.
  2. Cinieri, S.
  3. Garrido, P.
  4. Griesinger, F.
  5. Isla, D.
  6. Koehler, M.
  7. Kohlhaeufl, M.
Revue:
Lung Cancer

ISSN: 0169-5002,  1872-8332

Année de publication: 2012

Volumen: 76

Número: 3

Pages: 373-379

Type: Article

DOI: 10.1016/J.LUNGCAN.2011.11.020 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus